Charting Innovative

Drug Discovery

Designing and Executing
Preclinical Safety & Toxicology Studies
with Precision

Team

We are a team of experienced professionals in molecular and cellular biology, medicinal chemistry, pharmacology and toxicology with >15 years of industrial experience in drug discovery and R&D. Multiple milestones were achieved in projects with different Big pharma companies, and US or European institutions and universities.

We are ready to support your project at any stage of development from early discovery (assay setup, HTS, hit-to-lead, lead optimization) to the late preclinical.

⁺

Years Experience

About US

From Discovery to Clinical Readiness

Oncology, Immuno-oncology

Neuroinflammation

Multiple sclerosis, Alzheimer and Parkinson diseases

Autoimmune Diseases

Cardiometabolic

Virology

Medicinal chemistry

Custom assay development, assay transfer and validation

HTS campaigns (up to 200K screening libraries), H2L optimization

Development of project-specific secondary assays

Development of target engagement/biomarker assays

Animal efficacy models

ADME/DMPK

Safety pharmacology

Toxicology evaluation – from early DRF to GLP studies

Formulation development

Translational studies to support early clinical development

Our Mission

We help to bridge the gap between scientific innovation and clinical use.

OUR IDEA

With deep expertise across discovery and preclinical stages of drug development, we deliver compliant, fast-moving, and regulator-ready programs designed to translate into successful clinical outcomes.

Our services

Expert Preclinical Solutions Accelerating Development

Development Support

Expertise from discovery to preclinical ensures smooth toxicology and clinical transition.

Regulatory Optimization

Deep regulatory knowledge guides strategic design and execution of globally compliant studies.

Standards Compliance

All studies comply with ICH and GLP standards, ensuring regulatory acceptance worldwide.

Fast Timelines

We ensure rapid study starts and tight timelines to meet critical development milestones.

Risk Assessment

Thorough safety margin and toxicity assessments boost dose decisions and confidence.

Biomarker Integration

Custom assays for target engagement and biomarkers improve toxicology and dose selection.

Product

Multiple lines of
product title

We aspire to build a world where startups have access to the
right resources, strategic guidance, and unwavering support to
succeed. Our vision is to foster an ecosystem where innovation thrives, businesses grow seamlessly, and every entrepreneur has the opportunity to achieve lasting success.

Preclinical Services

We are working with different targets and different types of assays:

Enzymatic (kinases, phosphatases, proteases, polymerases ect.)

Binding, Protein-protein interactions

Cell-based assays (GPCR, ion channels, reporters, others)

Cell proliferation assays (viability, cell-cycle, apoptosis)

Assay platform to study targeted protein degradation (molecular glues, PROTACs)

Standard panel of in vitro and in vivo ADME/DMPK tests

Animal efficacy models

Safety pharmacology and Toxicology studies

Safety and toxicology studies

General toxicology

Single Ascending Dose studies;
Dose Range Finding studies;
Single dose (acute) studies;
Extended Single Dose studies;
Repeat-dose studies in rodents (up to 6 months) and non-rodents (up to 9 months).

Safety Pharmacology